Global Desalting and Buffer Exchange Market Insights and Analysis Report 2018
- sagar joshi
- Nov 19, 2018
- 1 min read
Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period.
Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. The increasing demand for monoclonal antibodies, increasing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to propel the growth of the market over the assessment period. On the other hand, the lack of skilled professionals is excepted to hinder the market growth during the forecast period.
Pune, India, November 2018/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Desalting and Buffer Exchange Market.
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/desalting-and-buffer-exchange-market-6633
Some of the prominent players in the global desalting and buffer exchange market are Merck KGaA, GE Healthcare, Sartorius AG, Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Avantor, Repligen Corporation, Bio-works Technologies Ab, Norgen Biotek Corp, and Phynexus, Inc.
Comments